ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
50 hedge funds and large institutions have $30.2M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
50
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.17M | |
| 3 | +$685K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$639K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$153K |
Top Sellers
| 1 | -$3.89M | |
| 2 | -$1.18M | |
| 3 | -$750K | |
| 4 |
EP
Eversept Partners
New York
|
-$299K |
| 5 |
HCA
Harbor Capital Advisors
Chicago,
Illinois
|
-$168K |